Poplawski SE, Hallett RM, Dornan MH, Novakowski KE, et al. Preclinical Development of PNT6555, a Boronic Acid-Based, Fibroblast Activation Protein-alpha (FAP)-Targeted Radiotheranostic for Imaging and Treatment of FAP-Positive Tumors. J Nucl Med 2024;65:100-108.
PMID: 38050111